Champions Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CSBR and other ETFs, options, and stocks.About CSBR
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice.
CEORobert Brainin
CEORobert Brainin
Employees213
Employees213
HeadquartersHackensack, New Jersey
HeadquartersHackensack, New Jersey
Founded1985
Founded1985
Employees213
Employees213
CSBR Key Statistics
Market cap85.35M
Market cap85.35M
Price-Earnings ratio30.23
Price-Earnings ratio30.23
Dividend yield—
Dividend yield—
Average volume10.40K
Average volume10.40K
High today$6.43
High today$6.43
Low today$6.07
Low today$6.07
Open price$6.43
Open price$6.43
Volume871.00
Volume871.00
52 Week high$11.99
52 Week high$11.99
52 Week low$4.31
52 Week low$4.31
Stock Snapshot
The current Champions Oncology(CSBR) stock price is $6.19, with a market capitalization of 85.35M. The stock trades at a price-to-earnings (P/E) ratio of 30.23.
During the trading session on 2025-12-08, Champions Oncology(CSBR) shares reached a daily high of $6.43 and a low of $6.07. At a current price of $6.19, the stock is +2.0% higher than the low and still -3.7% under the high.
Trading volume for Champions Oncology(CSBR) stock has reached 871, versus its average volume of 10.4K.
The stock's 52-week range extends from a low of $4.31 to a high of $11.99.
The stock's 52-week range extends from a low of $4.31 to a high of $11.99.
People also own
Based on the portfolios of people who own CSBR. This list is generated using Robinhood data, and it’s not a recommendation.